Large cell neuroblastoma
Tamás Tornóczky(Royal Victoria Infirmary), Hiroyuki Shimada(National Center for Geriatrics and Gerontology)
Cited by 50
Related Papers
Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children’s Oncology Group study
|British Journal of Cancer|2015|152
Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results
|Nature Medicine|2023|125
Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma
|Clinical Cancer Research|2018|88